Immunocore Holdings plc Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2023 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Immunocore Holdings plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2023 to Q1 2025.
- Immunocore Holdings plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was $435K.
- Immunocore Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was $26.1M, a 786% increase from 2023.
- Immunocore Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was $2.94M.
- Immunocore Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$49.2M, a 65.6% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)